Article · Wikipedia archive · Last revised Jun 7, 2026

MECR

Mitochondrial trans-2-enoyl-CoA reductase (MECR) is an enzyme that in humans is encoded by the MECR gene. It belongs to the enzyme class of oxidoreductases and catalyzes the last step of mitochondrial fatty acid synthesis (mtFAS). In doing so, MECR makes the fatty acyl chain bound to mitochondrial acyl carrier protein (mtACP) available again for elongation. MECR thereby contributes to mitochondrial respiration and oxidative phosphorylation. Beyond its mitochondrial role, a cytosolic and nuclear isoform (cMECR) has been linked to PPARα-dependent transcription. Pathogenic variants in the MECR gene cause MEPAN syndrome.

Last revised
Jun 7, 2026
Read time
≈ 6 min
Length
1,284 w
Citations
34
Source
MECR
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMECR, CGI-63, FASN2B, NRBF1, mitochondrial trans-2-enoyl-CoA reductase, ETR1, nuclear receptor binding factor 1, trans-2-enoyl-CoA reductase, mitochondrial, mitochondrial 2-enoyl thioester reductase
External IDsOMIM: 608205; MGI: 1349441; HomoloGene: 5362; GeneCards: MECR; OMA:MECR - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_025297

RefSeq (protein)

NP_079573

Location (UCSC)Chr 1: 29.19 – 29.23 MbChr 4: 131.57 – 131.6 Mb
PubMed search34
Wikidata
View/Edit HumanView/Edit Mouse

Mitochondrial trans-2-enoyl-CoA reductase (MECR) is an enzyme that in humans is encoded by the MECR gene.5 It belongs to the enzyme class of oxidoreductases and catalyzes the last step of mitochondrial fatty acid synthesis (mtFAS).6 In doing so, MECR makes the fatty acyl chain bound to mitochondrial acyl carrier protein (mtACP) available again for elongation.7 MECR thereby contributes to mitochondrial respiration and oxidative phosphorylation.8 Beyond its mitochondrial role, a cytosolic and nuclear isoform (cMECR) has been linked to PPARα-dependent transcription.9 Pathogenic variants in the MECR gene cause MEPAN syndrome.8

Structure

The MECR gene is located on chromosome 1 at locus p35.3 and contains 18 exons.6 Through alternative splicing, it produces nine protein-coding mRNA transcripts, which encode five isoforms of mitochondrial trans-2-enoyl-CoA reductase (MECR).6 The cMECR isoform lacks the N-terminal mitochondrial targeting sequence and localizes to the cytosol and nucleus.9

MECR forms a dimer with a bent substrate-binding cavity between the two monomers that accommodates acyl substrates with carbon chain lengths from C4 to C16.1011

Reaction

The reaction catalyzed by MECR can be summarized as follows:

trans-2-enoyl-mtACP + NADPH + H+acyl-mtACP + NADP+

Function

MECR catalyzes the last step of the mitochondrial fatty acid synthesis pathway. By using NADPH to reduce trans-2-enoyl-mtACP to saturated acyl-mtACP, MECR prepares the acyl chain for another round of elongation. source ↗

The MECR gene encodes mitochondrial trans-2-enoyl-CoA reductase, which catalyzes the last step of mitochondrial fatty acid synthesis (mtFAS).8 Condensation in mtFAS produces an unsaturated fatty acyl chain bound to mtACP.7 It must undergo reduction and dehydration reactions to become saturated, making it available again for the next elongation cycle.7 MECR completes this process by reducing the trans double bond between carbon atoms 2 and 3, yielding a saturated acyl-mtACP species.12 NADPH, whose availability in mitochondria depends on NADK2, provides the required reducing power.13 Through repeated elongation cycles, mitochondrial fatty acid synthesis generates acyl-mtACP species with chain lengths from C2 to C16.14 Octanoyl-mtACP (C8) serves as the precursor for lipoic acid biosynthesis and subsequent protein lipoylation, which is essential for several mitochondrial enzyme complexes, including the pyruvate dehydrogenase complex, the 2-oxoglutarate dehydrogenase complex, the branched-chain alpha-keto acid dehydrogenase complex, the 2-oxoadipate dehydrogenase complex, and the glycine cleavage system.15 Longer-chain acyl-mtACP species interact with LYRM proteins that are required for iron–sulfur cluster biogenesis and respiratory-chain assembly.15 In addition, mtFAS has been linked to mitochondrial translation and to levels of polyamines, including spermidine and spermine, as well as bioactive lipids such as lysophospholipids and sphingolipids.1310

MECR has also been reported to bind transcription factors of the PPAR family and activate transcription, suggesting a possible link between nuclear gene regulation and mtFAS.8

Clinical significance

Pathogenic variants in the MECR gene cause MEPAN syndrome, a rare autosomal recessive mitochondrial metabolic disorder characterized by childhood-onset dystonia, optic atrophy, and basal ganglia signal abnormalities on MRI.16 A later-onset phenotype with LHON-like optic neuropathy but without movement disorder or basal ganglia signal abnormalities has also been reported.171819

See also

See also

References

References

  1. GRCh38: Ensembl release 89: ENSG00000116353Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000028910Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Gene symbol report | HUGO Gene Nomenclature Committee". www.genenames.org. Retrieved 2026-05-19.
  6. "MECR mitochondrial trans-2-enoyl-CoA reductase [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2026-05-19.
  7. Nowinski SM, Solmonson A, Rusin SF, et al. (2020-08-17). "Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria". eLife. 9. doi:10.7554/eLife.58041. ISSN 2050-084X. PMC 7470841. PMID 32804083.
  8. Murdock DG, Janssen KA, Keller K, et al. (2025-10-07). "A mouse model of MEPAN demonstrates a role for mitochondrial fatty acid synthesis in iron–sulfur cluster and supercomplex formation". Proceedings of the National Academy of Sciences. 122 (40). doi:10.1073/pnas.2506761122. ISSN 0027-8424. PMC 12519216. PMID 41021813.
  9. Kim DG, Yoo JC, Kim E, et al. (2014). "A Novel Cytosolic Isoform of Mitochondrial Trans-2-Enoyl-CoA Reductase Enhances Peroxisome Proliferator-Activated Receptor α Activity". Endocrinology and Metabolism. 29 (2): 185. doi:10.3803/EnM.2014.29.2.185. ISSN 2093-596X. PMC 4091492. PMID 25031892.
  10. Clay HB, Parl AK, Mitchell SL, et al. (2016-03-10). Peterson J (ed.). "Altering the Mitochondrial Fatty Acid Synthesis (mtFASII) Pathway Modulates Cellular Metabolic States and Bioactive Lipid Profiles as Revealed by Metabolomic Profiling". PLOS ONE. 11 (3) e0151171. doi:10.1371/journal.pone.0151171. ISSN 1932-6203. PMC 4786287. PMID 26963735.
  11. Rahman MT, Koski MK, Panecka-Hofman J, et al. (2023-02-04). "An engineered variant of MECR reductase reveals indispensability of long-chain acyl-ACPs for mitochondrial respiration". Nature Communications. 14 (1). doi:10.1038/s41467-023-36358-7. ISSN 2041-1723. PMC 9899272. PMID 36739436.
  12. Wedan RJ, Longenecker JZ, Nowinski SM (January 2024). "Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism". Cell Metabolism. 36 (1): 36–47. doi:10.1016/j.cmet.2023.11.017. PMC 10843818. PMID 38128528.
  13. Wedan RJ, Nowinski SM (July 2025). "Powering the powerhouse: Mitochondrial NADPH propels oxidative metabolism". Cell Chemical Biology. 32 (7): 902–904. doi:10.1016/j.chembiol.2025.06.006. PMC 12507123. PMID 40680726.
  14. Kim D, Kesavan R, Ryu K, et al. (May 2025). "Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolism". Nature Cell Biology. 27 (5): 790–800. doi:10.1038/s41556-025-01655-4. ISSN 1465-7392. PMC 12331256. PMID 40258949.
  15. Wedan RJ, Longenecker JZ, Nowinski SM (January 2024). "Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism". Cell Metabolism. 36 (1): 36–47. doi:10.1016/j.cmet.2023.11.017. PMC 10843818. PMID 38128528.
  16. Heimer G, Kerätär JM, Riley LG, et al. (December 2016). "MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder". American Journal of Human Genetics. 99 (6): 1229–1244. doi:10.1016/j.ajhg.2016.09.021. PMC 5142118. PMID 27817865.
  17. Zhang S, Liu R, Liu Q, et al. (January 2026). "Mitochondrial fatty acid synthesis: The physiopathological role in cellular processes and human diseases". Genes & Diseases 102034. doi:10.1016/j.gendis.2026.102034. ISSN 2352-3042.
  18. Jia N, Yu S, Zhang G, et al. (April 2024). "Recurrent MECR R258W causes adult-onset optic atrophy: A case report". European Journal of Medical Genetics. 68 104917. doi:10.1016/j.ejmg.2024.104917. ISSN 1769-7212.
  19. Fiorini C, Degiorgi A, Cascavilla ML, et al. (January 2024). "Recessive MECR pathogenic variants cause an LHON-like optic neuropathy". Journal of Medical Genetics. 61 (1): 93–101. doi:10.1136/jmg-2023-109340. ISSN 0022-2593. PMC 10804020. PMID 37734847.
Further reading

Further reading